I think it is going to go reasonably well. As mentioned I
I think it is going to go reasonably well. As mentioned I just bought another 100K shares. Why? Because LL is a good medicine and CYDY has a core of 4 people who can either get LL a FDA approval or package CYDY into a partnership or buyout. There is a strong supporting cast and these 4 are:
Dr. Rae- Earned a PhD in virology and a JD. A pretty good combo that tells you he will work for something until he gets it. I suspect He has 3 or 4 Big Pharmas lined up waiting for further discussions about topline results or more likely a FDA approval. He didn't come back to CYDY just for grins, giggles and old times. He is the negotiator and very well equipped to match wits with BP, wherever in the world that may be and be well rewarded for doing so.
Dr. Recknor- Knows how to do a study and how to read the results. He will have the data in a form that the FDA will understand and can negotiate further studies with the FDA as they come up.
Tanya Urbach- Since she has been on the Oregon Securities Board since 2007 with a 4 year break, she has seen the mistakes that companies make that hurt their success first hand. Some criminal...some not. Now that she is the Board Chair she, along with SA bring a sense of doing business correctly to CYDY. I'd bet that NP, due to his overwhelming enthusiasm was considered to be a loose cannon, so was let go with a clear change in how information is to be distributed as a result. She knows what must be released to us shareholders and when.
Dr. Kelly- I think he is the glue that bonds together management and the board. He interacts with the CYDY members and probably keeps everybody there informed about what is happening. He knows LL. Plus he and Ms. Urbach are the ones most likely looking for the new CEO
So we have a good molecule and we have excellent people. I think it is going to go OK. It'll take longer than we think, because it always takes longer than it should to achieve anything of value.
13
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Surprising Win for a Rising Team In the world of sports, sometimes the odds are defied, and stories of triumph unfold that capture the imagination. The Golden State Valkyries did exactly that by snagging their first WNBA Championship title just a year after entering the league. It's a narrative right out of a Hollywood script—only this time, it's inked in real...
Continue Reading
Investors Eye Deadline Amidst Legal Storm Holy moly, Tenax Therapeutics is caught with their pants down—and we're not talking loose change. Any sorry soul who bought into Tenax's promises about their TNX-103 drug is now staring down a high-stakes class action lawsuit. If you were holding on to those dreams turned nightmares between November 13, 2023, and August 7, 2026,...
Continue Reading
Reddit and AI: Nicely Network's Winning Formula Straight out of New York comes the latest scoop: Nicely Network's been crowned king of the Reddit jungle, earning the title of Best Reddit Marketing Agency for Enterprise Brands this November, courtesy of Better Business Advice. Now, if you've been paying any attention to how brands are grappling with the impossible search...
Continue Reading
AppLovin’s Alleged Missteps: Investors Speak Up Earlier this year, folks holding AppLovin shares were sold a story of grand ambitions. The company's focus was on the promise of AI—dreams of skyrocketing revenue through innovative tools and self-service platforms. But as those promises struggled to take shape, investors pulled back the curtain, and the legal eagles...
Continue Reading
The Rise of Virtual K-Pop Across the Atlantic It's a bold new world for K-pop, and HYPEVERSE is leading the charge. Forget the typical idol group—this one's pulling out all the stops by going virtual and zeroing in on American audiences. Now, as someone who's been burned by the volatility of music stocks in the past, I'm peering at this development with a mix of...
Continue Reading
Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...
Continue Reading
Understanding Pain: Two Paths, One Problem Buttock and leg pain is a real drag, isn't it? We often brush it off as sciatica, but here's a twist: it might not be the usual corporate villain—a herniated disc. Instead, we could be dealing with an underdog called piriformis syndrome. According to Dr. Mitch Quill, D.C., of HelloNation fame, understanding these nuances isn't...
Continue Reading
Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...
Continue Reading
Steps Beyond the Obvious Adventure Launching headlong into the unknown—literally and figuratively—is what the documentary Jump Into The Unknown captures. TESSAN and Jamie Leibert have peeled back the curtain on adventure, showing us that it’s not just about the destination, but every twist, turn, and recalibrated step in between. The Backstory Behind Every Jump...
Continue Reading
XPeng Smashes Delivery Records Yet Again Ah, the green light’s on for XPeng, and it's a bright one! This October, we learned that XPeng hit the throttle hard with a new record of 50,237 vehicles delivered. Now, that's a sizable rally—a 22% climb month-over-month and shooting 20% higher than last October. For a company like XPeng, which resembles a bulldog with its...
Continue Reading
Top 5 Most Recently Viewed Articles
Cumberland Pharmaceuticals Set to Announce Q3 2024 Results Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, is gearing up to disclose its financial performance for the third quarter of 2024. This event will take place following the market's closure on a designated Thursday in November, allowing stakeholders to gain insight into the...
Continue Reading
Halliburton's Recent Performance Overview Halliburton Co. (NYSE: HAL) recently reported second-quarter earnings that surpassed revenue estimates while aligning with earnings expectations. Despite this promising financial report, shares traded lower, reflecting concerns stemming from CEO Jeff Miller's cautious outlook regarding the short-term oilfield services market....
Continue Reading
Urgent Need for Debt Ceiling Action The United States is at a critical juncture as Treasury Secretary Janet L. Yellen has stated that the government has less than three weeks to address its debt limit. Her announcement emphasizes the urgency of Congressional intervention. The Implications of Not Raising the Debt Limit Yellen conveyed her concerns through a letter to...
Continue Reading
Scenthound Highlights Importance of Pet Dental Care Month Nation's Leading Dog Wellness Franchise Champions Pet Health through Education, Services, and Innovative Products As we dive into the dedicated celebration of Pet Dental Health Month, Scenthound is at the forefront of emphasizing the essential role dental hygiene plays in the health of dogs. The franchise aims to...
Continue Reading
Charles Cynamon Takes the Helm at Telesat Government Solutions OTTAWA, Ontario and ARLINGTON, Va. – Telesat (NASDAQ and TSX: TSAT), a prominent player in the satellite industry, has appointed Charles "Chuck" Cynamon as President of Telesat Government Solutions. This division, dedicated to providing secure satellite solutions for U.S. Government civil, military, and...
Continue Reading